FeLV vaccination provides effective protection against a fatal disease in at-risk cats, with vaccination protocols reflecting risk-based recommendations that balance protection against the welfare implications of unnecessary vaccination.
FeLV vaccination welfare centers on the risk-benefit assessment for individual cats. For genuinely at-risk cats (outdoor exposure, multi-cat households with unscreened cats), vaccination provides meaningful protection against a uniformly fatal disease - the welfare benefit substantially outweighs the minor welfare cost of vaccination stress. For strictly indoor single-cat households, the risk of exposure is low, and vaccine site reactions (including rare injection-site sarcoma) represent a welfare cost without proportionate benefit. Welfare-informed vaccination protocols match vaccination intensity to actual risk, use the safest available formulations, and follow recommended injection site practices (rear leg placement allowing amputation if sarcoma develops).